Therapeutic drug monitoring of oral targeted antineoplastic drugs (Nov, 10.1007/s00228-020-03014-8, 2020)

被引：3

作者：

Mueller-Schoell, Anna ^{[1
,2
]}

Groenland, Stefanie L. ^{[3
]}

Scherf-Clavel, Oliver ^{[4
]}

van Dyk, Madele ^{[5
]}

Huisinga, Wilhelm ^{[6
]}

Michelet, Robin ^{[1
]}

Jaehde, Ulrich ^{[7
]}

Steeghs, Neeltje ^{[3
]}

Huitema, Alwin D. R. ^{[8
,9
]}

Kloft, Charlotte ^{[1
]}

机构：

[1] Free Univ Berlin, Inst Pharm, Dept Clin Pharm & Biochem, Berlin, Germany

[2] PharMetrX Berlin, Grad Res Training Program, Potsdam, Germany

[3] Netherlands Canc Inst Antoni Van Leeuwenhoek, Div Med Oncol, Dept Clin Pharmacol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands

[4] Julius Maximilians Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany

[5] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia

[6] Univ Potsdam, Inst Math, Potsdam, Germany

[7] Univ Bonn, Inst Pharm, Dept Clin Pharm, Bonn, Germany

[8] Netherlands Canc Inst Antoni Van Leeuwenhoek, Dept Pharm & Pharmacol, Amsterdam, Netherlands

[9] Univ Utrecht, Univ Med Ctr, Dept Clin Pharm, Utrecht, Netherlands

来源：

关键词：

Oral anticancer drugs; Personalised medicine; Targeted antineoplastic drugs; Therapeutic drug monitoring; Tyrosine kinase inhibitors;

D O I：

10.1007/s00228-020-03067-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A Correction to this paper has been published:

引用

页码：465 / 465

页数：1